Clinical Trials Logo

Clinical Trial Summary

40 patients who are consenting to be recruited in the study and are fulfilling the eligibility criteria will be subjected to: Group A Before the removal of uterus and the closure of vaginal cuff, insertion of 6inch 22G needle 2 to 3 cm below the umbilicus, 30 ml normal saline (sodium chloride solution 0.9%, FIPCO, Egypt)will be administered. While patients randomized to group B will undergo TLH with pre-sacral nerve block.


Clinical Trial Description

40 patients who are consenting to be recruited in the study and are fulfilling the eligibility criteria will be subjected to: Group A Before the removal of uterus and the closure of vaginal cuff, insertion of 6inch 22G needle 2 to 3 cm below the umbilicus, 30 ml normal saline (sodium chloride solution 0.9%, FIPCO, Egypt)will be administered , then the uterus will be removed, and the operation will be terminated While patients randomized to group B will undergo TLH with pre-sacral nerve block as follows: Uterosacral nerve block will be performed before the removal of uterus and the closure of vaginal cuff, and before the removal of trocars from abdominal cavity, insertion of 6-inch 22G needle 2 to 3 cm below the umbilicus, injection of the SHP area which situated anterior to L5-S1 vertebral bodies, Caudal to the bifurcation of the abdominal aorta with 30 ml 0.25% bupivacaine (Marcaine®0.25% , Astra Zeneca, Egypt) will be administered. Following the injection of local anesthetic, patient will be placed from Trendelenburg position to horizontal position. The we will remove the uterus and trocars , and the operation will be terminated. Data will be recorded in a case report form (CRF) and statistical analysis will be done. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05757011
Study type Interventional
Source Ain Shams University
Contact Rana M Wagdy, Lecturer
Phone 01011431780
Email Ranawagdy5@gmail.com
Status Recruiting
Phase N/A
Start date January 5, 2020
Completion date August 10, 2023

See also
  Status Clinical Trial Phase
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Completed NCT02638688 - Measurement of Fibroid Volume and 2D, 3D US N/A
Not yet recruiting NCT02769325 - Atropine in Laparoscopic Gynaecological Surgery Phase 4
Active, not recruiting NCT01697566 - An Endometrial Cancer Chemoprevention Study of Metformin Phase 3
Withdrawn NCT04089852 - Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women Phase 2/Phase 3
Recruiting NCT03589352 - Women's Knowledges About Gynaecological Aftercare
Recruiting NCT04737473 - The Comparative Efficacy and Safety of Two General Anesthesia Protocols Consisting of Fentanyl Plus Propofol Plus Rococuronium Plus Isoflurane Versus Ketamime Plus Magnesium Sulphate Plus Lidocaine Plus Clonidine Plus Propofol Plus Rococuronium Plus Isoflurane for Gynaecology Surgery in Cameroon N/A
Completed NCT02274441 - Activity and Quality of Care Indicators' for a Sentinel Network Creation N/A
Completed NCT03805386 - Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery Phase 2/Phase 3
Completed NCT06324019 - Gynaecological Examination Gown and Patient Satisfaction N/A
Recruiting NCT06394752 - UTERINE EVALUATION FOR THE IDENTIFICATION OF PATHOLOGY. This Study Will Compare the Intrauterine Pathology Detection Rate Between Standard of Care Hydrosonography, and a New Visual Saline Infusion Device Providing Direct Visualization of the Uterus. N/A
Recruiting NCT06388590 - Acupuncture for Chronic Pelvic Pain N/A
Completed NCT02800031 - IOTA Versus Pattern Recognition Method in Diagnosis of Ovarian Masses N/A